drugset / Trial / NCT05068349

For Patients With Ischemic Stroke, Clinically Study the Effectiveness and Safety of Butylphthalide.

NCT05068349

Phase 4 Unknown 300 enrolled Qianfoshan Hospital
NaSingle-groupOpen-labelTreatment

Summary

This is a prospective, open, single-arm, the real world of clinical trials. The researchers plan to recruit 300 eligible patients. The main purpose of this study is to evaluate the effectiveness and safety of butylphthalide in the treatment of ischemic stroke, and to establish a population pharmacokinetic model of butylphthalide in elderly patients to explore its blood drug concentration. Correlation with its efficacy and adverse reactions.

Timeline

Start
2022-05-07
Primary completion
2025-09
Completion
2025-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Butylphthalide Small molecule 0.2 g Intravenous